Understanding Depression (eBook, PDF)
Volume 2. Clinical Manifestations, Diagnosis and Treatment
171,19 €
inkl. MwSt.
Sofort per Download lieferbar
Understanding Depression (eBook, PDF)
Volume 2. Clinical Manifestations, Diagnosis and Treatment
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book, in two volumes, focuses on contemporary issues and dilemmas in relation to depression. The aim is to equip readers with an up-to-date understanding of the clinical and neurobiological underpinnings of depression, the clinical manifestations, and the development of more effective treatments. This second volume is devoted specifically to clinical and management issues. Readers will find detailed information on a wide range of frequently encountered and more complicated clinical presentations, with examination of risk factors and links to other conditions. Diagnostic aspects, including…mehr
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 5.36MB
- Upload möglich
Andere Kunden interessierten sich auch für
- Ketamine for Treatment-Resistant Depression (eBook, PDF)85,59 €
- Sleep Disorders (eBook, PDF)74,89 €
- Sleepiness and Human Impact Assessment (eBook, PDF)96,29 €
- Fatigue Management (eBook, PDF)90,94 €
- Understanding Depression (eBook, PDF)171,19 €
- Postmenopausal Diseases and Disorders (eBook, PDF)96,29 €
- Obstructive Sleep Apnea (eBook, PDF)213,99 €
-
-
-
This book, in two volumes, focuses on contemporary issues and dilemmas in relation to depression. The aim is to equip readers with an up-to-date understanding of the clinical and neurobiological underpinnings of depression, the clinical manifestations, and the development of more effective treatments. This second volume is devoted specifically to clinical and management issues. Readers will find detailed information on a wide range of frequently encountered and more complicated clinical presentations, with examination of risk factors and links to other conditions. Diagnostic aspects, including progress toward biological classification and the role of neuroimaging, are explored. Current trends in therapy are examined at length, drawing on the latest evidence and covering not only antidepressant medications but also the roles of neurostimulation, combined pharmacotherapy and psychotherapy, mindfulness-based cognitive therapy, and complementary and alternative medicine. The companion volume is dedicated to the underlying biomedical and neurobiological basis of depression. Understanding Depression will be an excellent source of information for both researchers and practitioners in the field.
Produktdetails
- Produktdetails
- Verlag: Springer Singapore
- Erscheinungstermin: 2. Januar 2018
- Englisch
- ISBN-13: 9789811065774
- Artikelnr.: 52540404
- Verlag: Springer Singapore
- Erscheinungstermin: 2. Januar 2018
- Englisch
- ISBN-13: 9789811065774
- Artikelnr.: 52540404
Yong-Ku Kim, MD, PhD is a Professor of Psychiatry at College of Medicine, Korea University. He received a MD degree from College of Medicine, Korea University in 1987 and a PHD in psychiatry from Korea University in 1998. Dr. Kim has been affiliated with Korea University since 1998, first as an assistant professor (1998-2000), then as associated professor (2001-2005), professor (2006- present). For the past 20 years, his professional activities have extended beyond the area of pure clinical or research work. Dr. Kim has well over 200 publications in peer-reviewed international journals, including Biological Psychiatry, Molecular Psychiatry, Clinical Journal of Psychiatry, and Progress in Neuropsychopharmacology and Biological Psychiatry and 30 publications of book chapters and have made over 90 academic presentations in my area of interest. Dr. Kim is a fellow of Collogicum Internationale Neuropsychopharmacologicum, International Society for Affective Disorders, World Federation of the Society of biological Psychiatry. He currently sits on the editorial boards of some leading academic journals in the field of neurobiology, including Progress in Neuropsychopharmacology and Biological Psychiatry, Psychiatry Investigation, World Journal Psychiatry, Annals of Depression and Anxiety, Psychiatry Journal and so on. Dr. Kim received prestigious awards such as Astrageneca Award and Dr. Paul Janssen Schizophrenia Research Award. Dr. Kim is currently the president of Korean society of Biological Psychiatry (2016-present).
1.Diagnostic issues of depression.- 1-1.Major depression and bipolar depression: similarity, difference and contemporary treatment approach.- 1-2.Biomarkers of depression-potential diagnostic tools.- 1-3.Diagnosis of depression: from clinical classification to biological classification.- 1-4.Application of neuroimaging in the diagnosis and treatment in depression.- 2.Clinical manifestations of depression.- 2-1.Anhedonia as a crucial factor of depression; assessment, neurobiological underpinning and treatment.- 2-2.Sleep and sleep disorders in depression.- 2-3.Chronobiology and treatment in depression.- 2-4.Suicide in depression: risk factors, neurobiology and treatment.- 2-5.Cognitive dimension of depression; assessment, neurobiology and treatment.- 2-6.Risk factors and prevention strategy of depression in childhood and adolescence.- 2-7.Neurobiology and risk factors in late life depression.- 3.Complicated clinical manifestations of depression.- 3-1.Overlapping chronic pain and depression: pathophysiology and management.- 3-2.Clinical, biological and therapeutic characteristics between depression with and without medical illness.- 3-3.Biological mechanism underlying the link Depression and cardiovascular disease.- 3-4.Bunout syndrome and depression.- 3-5.The link between obesity and depression: exploring shared mechanisms.- 3-6.Biomarkers, detection and therapeutic approaches for antenatal and postnatal depression.- 4.Therapeutic issues of depression.- 4-1.Ketamine: a promising rapid-acting antidepressant in depression.- 4-2.Antidepressant therapy for depression: An update.- 4-3.The use of atypical antipsychotics in treatment of depression: efficacy and safety.- 4-4.Neurobiology and therapeutic approach in treatment-resistant depression (TRD).- 4-5.Clinical application of neurostimulation in depression.- 4-6.Combination therapy of pharmacotherapy and psychotherapy in depression: Is it really superior to either treatment alone?.- 4-7.Mindfulness-based cognitive therapy for depression: preference to internet-based mental health and psychotherapy approaches in mood disorders.- 4-8.Current research on complementary and alternative medicine (CAM) in the treatments of depression: evidence based review.
1.Diagnostic issues of depression.- 1-1.Major depression and bipolar depression: similarity, difference and contemporary treatment approach.- 1-2.Biomarkers of depression-potential diagnostic tools.- 1-3.Diagnosis of depression: from clinical classification to biological classification.- 1-4.Application of neuroimaging in the diagnosis and treatment in depression.- 2.Clinical manifestations of depression.- 2-1.Anhedonia as a crucial factor of depression; assessment, neurobiological underpinning and treatment.- 2-2.Sleep and sleep disorders in depression.- 2-3.Chronobiology and treatment in depression.- 2-4.Suicide in depression: risk factors, neurobiology and treatment.- 2-5.Cognitive dimension of depression; assessment, neurobiology and treatment.- 2-6.Risk factors and prevention strategy of depression in childhood and adolescence.- 2-7.Neurobiology and risk factors in late life depression.- 3.Complicated clinical manifestations of depression.- 3-1.Overlapping chronic pain and depression: pathophysiology and management.- 3-2.Clinical, biological and therapeutic characteristics between depression with and without medical illness.- 3-3.Biological mechanism underlying the link Depression and cardiovascular disease.- 3-4.Bunout syndrome and depression.- 3-5.The link between obesity and depression: exploring shared mechanisms.- 3-6.Biomarkers, detection and therapeutic approaches for antenatal and postnatal depression.- 4.Therapeutic issues of depression.- 4-1.Ketamine: a promising rapid-acting antidepressant in depression.- 4-2.Antidepressant therapy for depression: An update.- 4-3.The use of atypical antipsychotics in treatment of depression: efficacy and safety.- 4-4.Neurobiology and therapeutic approach in treatment-resistant depression (TRD).- 4-5.Clinical application of neurostimulation in depression.- 4-6.Combination therapy of pharmacotherapy and psychotherapy in depression: Is it really superior to either treatment alone?.- 4-7.Mindfulness-based cognitive therapy for depression: preference to internet-based mental health and psychotherapy approaches in mood disorders.- 4-8.Current research on complementary and alternative medicine (CAM) in the treatments of depression: evidence based review.
1.Diagnostic issues of depression.- 1-1.Major depression and bipolar depression: similarity, difference and contemporary treatment approach.- 1-2.Biomarkers of depression-potential diagnostic tools.- 1-3.Diagnosis of depression: from clinical classification to biological classification.- 1-4.Application of neuroimaging in the diagnosis and treatment in depression.- 2.Clinical manifestations of depression.- 2-1.Anhedonia as a crucial factor of depression; assessment, neurobiological underpinning and treatment.- 2-2.Sleep and sleep disorders in depression.- 2-3.Chronobiology and treatment in depression.- 2-4.Suicide in depression: risk factors, neurobiology and treatment.- 2-5.Cognitive dimension of depression; assessment, neurobiology and treatment.- 2-6.Risk factors and prevention strategy of depression in childhood and adolescence.- 2-7.Neurobiology and risk factors in late life depression.- 3.Complicated clinical manifestations of depression.- 3-1.Overlapping chronic pain and depression: pathophysiology and management.- 3-2.Clinical, biological and therapeutic characteristics between depression with and without medical illness.- 3-3.Biological mechanism underlying the link Depression and cardiovascular disease.- 3-4.Bunout syndrome and depression.- 3-5.The link between obesity and depression: exploring shared mechanisms.- 3-6.Biomarkers, detection and therapeutic approaches for antenatal and postnatal depression.- 4.Therapeutic issues of depression.- 4-1.Ketamine: a promising rapid-acting antidepressant in depression.- 4-2.Antidepressant therapy for depression: An update.- 4-3.The use of atypical antipsychotics in treatment of depression: efficacy and safety.- 4-4.Neurobiology and therapeutic approach in treatment-resistant depression (TRD).- 4-5.Clinical application of neurostimulation in depression.- 4-6.Combination therapy of pharmacotherapy and psychotherapy in depression: Is it really superior to either treatment alone?.- 4-7.Mindfulness-based cognitive therapy for depression: preference to internet-based mental health and psychotherapy approaches in mood disorders.- 4-8.Current research on complementary and alternative medicine (CAM) in the treatments of depression: evidence based review.
1.Diagnostic issues of depression.- 1-1.Major depression and bipolar depression: similarity, difference and contemporary treatment approach.- 1-2.Biomarkers of depression-potential diagnostic tools.- 1-3.Diagnosis of depression: from clinical classification to biological classification.- 1-4.Application of neuroimaging in the diagnosis and treatment in depression.- 2.Clinical manifestations of depression.- 2-1.Anhedonia as a crucial factor of depression; assessment, neurobiological underpinning and treatment.- 2-2.Sleep and sleep disorders in depression.- 2-3.Chronobiology and treatment in depression.- 2-4.Suicide in depression: risk factors, neurobiology and treatment.- 2-5.Cognitive dimension of depression; assessment, neurobiology and treatment.- 2-6.Risk factors and prevention strategy of depression in childhood and adolescence.- 2-7.Neurobiology and risk factors in late life depression.- 3.Complicated clinical manifestations of depression.- 3-1.Overlapping chronic pain and depression: pathophysiology and management.- 3-2.Clinical, biological and therapeutic characteristics between depression with and without medical illness.- 3-3.Biological mechanism underlying the link Depression and cardiovascular disease.- 3-4.Bunout syndrome and depression.- 3-5.The link between obesity and depression: exploring shared mechanisms.- 3-6.Biomarkers, detection and therapeutic approaches for antenatal and postnatal depression.- 4.Therapeutic issues of depression.- 4-1.Ketamine: a promising rapid-acting antidepressant in depression.- 4-2.Antidepressant therapy for depression: An update.- 4-3.The use of atypical antipsychotics in treatment of depression: efficacy and safety.- 4-4.Neurobiology and therapeutic approach in treatment-resistant depression (TRD).- 4-5.Clinical application of neurostimulation in depression.- 4-6.Combination therapy of pharmacotherapy and psychotherapy in depression: Is it really superior to either treatment alone?.- 4-7.Mindfulness-based cognitive therapy for depression: preference to internet-based mental health and psychotherapy approaches in mood disorders.- 4-8.Current research on complementary and alternative medicine (CAM) in the treatments of depression: evidence based review.